WebMar 8, 2024 · Hirokazu Tozaki works as a Senior Director at Chordia Therapeutics, with an estimated 7 employees. Their management level is Director. Found email listings include: @chordiatherapeutics.com. Read More . Contact. Hirokazu Tozaki's Phone Number and Email Last Update. 3/8/2024 7:20 AM. Email. WebTop Chordia Therapeutics Integrations and Technologies. Here's a list of some of the top trending technologies and APIs used by Chordia Therapeutics. Content Delivery …
Chordia Therapeutics Inc LinkedIn
WebChordia Therapeutics Inc. Foundation November 1, 2024 Head Office 26-1, Muraoka-Higashi 2-chome, Fujisawa, Kanagawa 251-0012 Japan Tokyo Office 3-11-5,Nihonbashi-honcho, Chuo-ku,Tokyo 103-0023 Japan … WebChordia Therapeutics Inc 165 followers 3mo Report this post Report Report. Back Submit. We delight to announce progress of the Phase 1 Clinical Trial of CLK Inhibitor CTX-712 at the 64th ASH ... famos need for speed
Chordia Therapeutics株式会社の会社情報と資金調達 NIKKEI …
WebChordia Therapeutics Summary. Company summary. Overview. Chordia Therapeutics is an oncology research and development company. It provides a pan-CDC-like kinase inhibitor and accelerates other pre-clinical programs towards clinical trials. Type Private Status Active Founded 2024 HQ Webジャフコ グループ株式会社は1973年の創業以来、常に時代をリードする起業家とともに歩んできました。国内外における運用ファンドの累計コミットメント額は1兆円を超え、 … WebDec 15, 2024 · Chordia Therapeutics Inc is an oncology drug discovery and development company focusing on advancing innovative assets to deliver transformative therapies to cancer patients since its foundation in November 2024 at Shonan Health Innovation Park, Kanagawa, Japan. Chordia’s lead asset CTX-712, a CLK inhibitor, is under Phase 1 … famoso head office